Literature DB >> 22006980

Leucoencephalopathy with brainstem and spinal cord involvement and high lactate: quantitative magnetic resonance imaging.

Marianne E Steenweg1, Petra J W Pouwels, Nicole I Wolf, Wessel N van Wieringen, Frederik Barkhof, Marjo S van der Knaap.   

Abstract

Leucoencephalopathy with brainstem and spinal cord involvement and elevated lactate is a white matter disorder caused by DARS2 mutations. The pathology is unknown. We observed striking discrepancies between improvement on longitudinal conventional magnetic resonance images and clinical deterioration and between large areas of high signal on diffusion-weighted imaging and small areas with low apparent diffusion coefficient values. These observations prompted a longitudinal and quantitative magnetic resonance imaging study. We investigated eight patients (two males, mean age 27 years). Maps of T(2) relaxation times, fractional anisotropy, apparent diffusion coefficients, signal on diffusion-weighted imaging, and axial and radial diffusivities were generated. Brain metabolites, obtained by chemical shift imaging, were quantified. Data analysis focused on: (i) white matter with low apparent diffusion coefficient; (ii) white matter with high T(2) values; (iii) white matter with intermediate T(2) values; and (iv) normal-appearing white matter. The areas were compared with similarly located areas in eight matched controls. In five patients, T(2)-weighted images, spectroscopy, apparent diffusion coefficient maps and diffusion-weighted imaging maps were compared with those obtained 5-7 years ago. In white matter with low apparent diffusion coefficient, axial and radial diffusivities were decreased and fractional anisotropy was high. T(2) values were intermediate. These areas with truly restricted diffusion were small and often observed at the periphery of areas with high T(2) values. In the white matter with high and intermediate T(2) values, apparent diffusion coefficients and axial and radial diffusivities were increased and fractional anisotropy decreased. The signal on diffusion-weighted imaging was highest in white matter with high T(2) values, an effect of T(2) shinethrough. Chemical shift imaging in both white matter types showed increased lactate, increased myo-inositol and decreased N-acetylaspartate, most pronounced in white matter with high T(2) values. Normal-appearing white matter was comparable with white matter of control subjects. Over time, mild decreases in T(2) signal intensities, signal on diffusion-weighted imaging and in extent of the low apparent diffusion coefficient areas were seen. In conclusion, the disease process in leucoencephalopathy with brainstem and spinal cord involvement and elevated lactate is extremely slow. We hypothesize that diffusion restriction is the first stage of the disease caused by intramyelinic water accumulation, followed by slow shift and then loss of the surplus of water. On conventional T(2) images this leads to improvement. We hypothesize that it is loss of water rather than structural restoration that causes the change in T(2) signal intensity, which would be in better agreement with the slow clinical deterioration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22006980     DOI: 10.1093/brain/awr254

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  11 in total

1.  A case with leukoencephalopathy with brainstem and spinal cord involvement and elevated lactate (LBSL) with Its Characteristic Clinical and Neuroimaging Findings.

Authors:  H Alibas; P K Koytak; G Ekinci; K Uluc
Journal:  Clin Neuroradiol       Date:  2013-09-05       Impact factor: 3.649

2.  Clinical reasoning: a 55-year-old man with weight loss, ataxia, and foot drop.

Authors:  Eoin P Flanagan; Andrea N Leep Hunderfund; Neeraj Kumar; Joseph A Murray; Karl N Krecke; Brian S Katz; Sean J Pittock
Journal:  Neurology       Date:  2014-06-17       Impact factor: 9.910

3.  Compound Heterozygous DARS2 Mutations as a Mimic of Hereditary Spastic Paraplegia.

Authors:  Martje G Pauly; Yorck Hellenbroich; Kathrin Grundmann-Hauser; Frauke Hinrichs; Katja Lohmann; Norbert Brüggemann
Journal:  Mov Disord Clin Pract       Date:  2021-06-14

4.  NUBPL mutations in patients with complex I deficiency and a distinct MRI pattern.

Authors:  Sietske H Kevelam; Richard J Rodenburg; Nicole I Wolf; Patrick Ferreira; Roelineke J Lunsing; Leo G Nijtmans; Anne Mitchell; Hugo A Arroyo; Dietz Rating; Adeline Vanderver; Carola G M van Berkel; Truus E M Abbink; Peter Heutink; Marjo S van der Knaap
Journal:  Neurology       Date:  2013-04-03       Impact factor: 9.910

5.  Revisiting mitochondrial diagnostic criteria in the new era of genomics.

Authors:  Peter Witters; Ann Saada; Tomas Honzik; Marketa Tesarova; Stephanie Kleinle; Rita Horvath; Amy Goldstein; Eva Morava
Journal:  Genet Med       Date:  2017-10-26       Impact factor: 8.822

6.  Biallelic variants in LARS2 and KARS cause deafness and (ovario)leukodystrophy.

Authors:  Marjo S van der Knaap; Marianna Bugiani; Marisa I Mendes; Lisa G Riley; Desiree E C Smith; Joëlle Rudinger-Thirion; Magali Frugier; Marjolein Breur; Joanna Crawford; Judith van Gaalen; Meyke Schouten; Marjolaine Willems; Quinten Waisfisz; Frederic Tran Mau-Them; Richard J Rodenburg; Ryan J Taft; Boris Keren; John Christodoulou; Christel Depienne; Cas Simons; Gajja S Salomons; Fanny Mochel
Journal:  Neurology       Date:  2019-02-08       Impact factor: 11.800

Review 7.  Mitochondrial disorders: challenges in diagnosis & treatment.

Authors:  Nahid Akhtar Khan; Periyasamy Govindaraj; Angamuthu Kannan Meena; Kumarasamy Thangaraj
Journal:  Indian J Med Res       Date:  2015-01       Impact factor: 2.375

8.  Loss-of-function mutations in ISCA2 disrupt 4Fe-4S cluster machinery and cause a fatal leukodystrophy with hyperglycinemia and mtDNA depletion.

Authors:  Joseph T Alaimo; Arnaud Besse; Charlotte L Alston; Ki Pang; Vivek Appadurai; Monisha Samanta; Patroula Smpokou; Robert McFarland; Robert W Taylor; Penelope E Bonnen
Journal:  Hum Mutat       Date:  2018-01-22       Impact factor: 4.878

9.  Novel (ovario) leukodystrophy related to AARS2 mutations.

Authors:  Cristina Dallabona; Daria Diodato; Sietske H Kevelam; Tobias B Haack; Lee-Jun Wong; Gajja S Salomons; Enrico Baruffini; Laura Melchionda; Caterina Mariotti; Tim M Strom; Thomas Meitinger; Holger Prokisch; Kim Chapman; Alison Colley; Helena Rocha; Katrin Ounap; Raphael Schiffmann; Ettore Salsano; Mario Savoiardo; Eline M Hamilton; Truus E M Abbink; Nicole I Wolf; Ileana Ferrero; Costanza Lamperti; Massimo Zeviani; Adeline Vanderver; Daniele Ghezzi; Marjo S van der Knaap
Journal:  Neurology       Date:  2014-05-07       Impact factor: 9.910

Review 10.  Mitochondrial aminoacyl-tRNA synthetase disorders: an emerging group of developmental disorders of myelination.

Authors:  Amena Smith Fine; Christina L Nemeth; Miriam L Kaufman; Ali Fatemi
Journal:  J Neurodev Disord       Date:  2019-12-16       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.